JP Morgan Chase
IRON icon

JP Morgan Chase’s Disc Medicine IRON Stock Holding History

JP Morgan Chase’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-40,000
Closed -$2.31M – 7633
2023
Q4 		$2.31M Buy
+40,000
New +$2.05M ﹤0.01% 3728

Other funds holding IRON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

JP Morgan Chase's IRON Position: Q2 2026 in Review

JP Morgan Chase increased its Disc Medicine (IRON) stake by 37% in Q2 2026, buying an estimated $34.7M and bringing the position to 1,875,795 shares worth $140M. The position accounts for 0.01% of the portfolio, ranked #906.

JP Morgan Chase first reported a position in IRON in Q1 2021 and has held it in 19 quarters since. 128 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • JP Morgan Chase held 1,875,795 shares of Disc Medicine worth $140M as of Q2 2026.
  • JP Morgan Chase bought 504,315 Disc Medicine shares in Q2 2026, an estimated $34.7M.
  • Disc Medicine made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #906 holding.
  • JP Morgan Chase first reported a position in Disc Medicine in Q1 2021 and has held it in 19 quarters since.
  • 128 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.